Literature DB >> 29109583

Should Digoxin Continue To Be Used for the Management of Atrial Fibrillation?

.   

Abstract

Entities:  

Year:  2017        PMID： 29109583      PMCID： PMC5659251          DOI： 10.4212/cjhp.v70i5.1701

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  18 in total

Review 1.  Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation.

Authors:  Ai-Jun Ouyang; Yan-Ni Lv; Hai-Li Zhong; Jin-Hua Wen; Xiao-Hua Wei; Hong-Wei Peng; Jian Zhou; Li-Li Liu
Journal:  Am J Cardiol       Date:  2015-01-14       Impact factor: 2.778

Review 2.  Chronic atrial fibrillation: a systematic review of medical heart rate control management.

Authors:  T Nikolaidou; K S Channer
Journal:  Postgrad Med J       Date:  2009-06       Impact factor: 2.401

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.

Authors:  Ali Ahmed; Michael W Rich; Thomas E Love; Donald M Lloyd-Jones; Inmaculada B Aban; Wilson S Colucci; Kirkwood F Adams; Mihai Gheorghiade
Journal:  Eur Heart J       Date:  2005-12-08       Impact factor: 29.983

5.  Interaction between digoxin and dronedarone in the PALLAS trial.

Authors:  Stefan H Hohnloser; Jonathan L Halperin; A John Camm; Peggy Gao; David Radzik; Stuart J Connolly
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-11-06

6.  Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.

Authors:  James V Freeman; Kristi Reynolds; Margaret Fang; Natalia Udaltsova; Anthony Steimle; Niela K Pomernacki; Leila H Borowsky; Teresa N Harrison; Daniel E Singer; Alan S Go
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-11-20

Review 7.  Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation.

Authors:  Waqas Qureshi; Wesley T O'Neal; Elsayed Z Soliman; Mouaz H Al-Mallah
Journal:  Cardiol J       Date:  2016-04-11       Impact factor: 2.737

8.  Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation.

Authors:  R Lang; H O Klein; E Weiss; D David; P Sareli; A Levy; J Guerrero; E Di Segni; E Kaplinsky
Journal:  Chest       Date:  1983-03       Impact factor: 9.410

Review 9.  Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased Mortality.

Authors:  Surbhi Chamaria; Anand M Desai; Pratap C Reddy; Brian Olshansky; Paari Dominic
Journal:  Cardiol Res Pract       Date:  2015-12-14       Impact factor: 1.866

10.  Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.

Authors:  Naqash J Sethi; Sanam Safi; Joshua Feinberg; Emil E Nielsen; Christian Gluud; Janus C Jakobsen
Journal:  Syst Rev       Date:  2017-04-05
View more
  1 in total

1.  Comparative effectiveness of common treatments for new-onset atrial fibrillation within the ICU: Accounting for physiological status.

Authors:  Jonathan P Bedford; Alistair Johnson; Oliver Redfern; Stephen Gerry; James Doidge; David Harrison; Kim Rajappan; Kathryn Rowan; J Duncan Young; Paul Mouncey; Peter J Watkinson
Journal:  J Crit Care       Date:  2021-11-16       Impact factor: 3.425
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.